Pharmacy Disclosure Log 2020
- Antiretroviral Therapies Response 5560
- Anit VEGF Treatment Response 5329
- Biologics & Biosimilar Prescribing in Rheumatology Response 5093
- Biologics and Biosimilar Products Response 5428
- Breast Cancer Treatment Response 5445
- Dermatology Treatment Response 5553
- Dermatology Treatment Response 5440
- Dermatology Biologics Response 5140
- Dispensed Products Response 5256
- Delirium Response 5373
- Delirium Response 5373 - Attachment
- Free of Charge Medication Response 5379
- Gastro Biologics Response 5124
- Intra-Vitreal Injections or Implants Response 5303
- Ophthalmology Prescribing Response 5201
- Osteoporosis Treatment Response 5250
- Medication Response 5390
- Patients being Treated for Metastatic Non-Small-Cell Lung Cancer Response 5313
- Patients being Treated for Metastatic Non-Small-Cell Lung Cancer Response 5313 - Attachment
- Patient Group Directive Response 5152
- Patients Treated for Asthma Response 5249
- Patients Treated with Specific Drugs Response 5282
- Patients Treated for Colorectal Cancer Response 5283
- Patients Treated with Specific Drugs Response 5319
- Patients Treated for Colorectal Cancer Response 5283 - Attachment
- Patients Treated for Severe Asthma Response 5383
- Patients Treated with Specific Drugs Response 5387
- Prescribing regardless of Diagnosis Response 5262
- Prescribing Data for CBPMs Response 5098
- ULMs and UK Unlicensed Specials Response 5142
- ULMs and UK Unlicensed Specials Response 5142 Attachment
- Usage Sodium Chloride 5% Response 5121
Last Modified: 12:04pm 05/10/2022